Los videos son el contenido audiovisual más amado por la audiencia de todo el mundo gracias a las nuevas tecnologías que permiten crear clip de calidad profesional con efectos cinematográficos que dejan sin aliento. Todos los programas para editar videos que existen hoy …
Cómo eliminar o cambiar el fondo de tu video con IA sin necesidad de una pantalla verde Read More »
Chroma Medicine, Inc., a genomic medicine company pioneering single-dose epigenetic editing therapeutics, presented data demonstrating the advantages of epigenetic editing for multiplex gene regulation at the American Society of Gene & Cell Therapy 26th Annual Meeting in Los Angeles.
2seventy bio, Inc. announced late-breaking results from the ongoing Phase 1 PLAT-08 trial, in collaboration with Seattle Children’s Therapeutics, evaluating SC-DARIC33 in relapsed or refractory pediatric and young adult AML patients, as well as an oral presentation evaluating regulated IL-15 production combined with DARIC33 activation for anti-AML potency.
Alvotech, a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, reported unaudited financial results for the first three months of 2023 and provided a summary of recent corporate highlights.
En este Short conoceremos una especie de hormiga con un comportamiento muy peculiar. …
¿Las hormigas saben fingir una muerte colectiva? Read More »
La energía solar fotovoltaica y los paneles solares han experimentado un crecimiento exponencial en los últimos años, convirtiéndose en una de las fuentes de energía más prometedoras y sostenibles del mundo. Con el aumento de la conciencia ambiental y la b&u …
Energía Solar Fotovoltaica: La Revolución de los Paneles Solares Read More »
AlzeCure Pharma AB announced that Janet Hoogstraate is newly elected to AlzeCure’s board.
Dr. Janet Hoogstraate New Board Member of AlzeCure Pharma Read More »
CorFlow Therapeutics AG has announced the interim positive results of its MOCA I study at EuroPCR in Paris, France.
Sobi announced that the European Medicines Agency has accepted and validated a marketing authorisation application for efanesoctocog alfa, a new class of high-sustained FVIII developed for the treatment of people with haemophilia A of all age groups.
Humanetics Biomed is a Contract Development Manufacturing Organisation that combines the best biomedical technologies from Humanetics; with the technical engineering expertise for research and development of precision lasered components and subcomponents for medical devices.
Humanetics Biomed expands its outsourced manufacturing capabilities to new markets Read More »
